We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

G.I. No

16 August 2010 By George Hay

The UK insurer has rebuffed a 5 billion stg approach for its subsidiary from rival RSA. The offer looks on the low end, and Aviva claims that its diversified approach brings benefits. But it will need to persuade shareholders these are worth more than a sale.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)